Fengming Ding
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Asthma and respiratory diseases
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
- Cystic Fibrosis Research Advances 3
-
- Asthma and respiratory diseases 4
- Co-authors
- Guogang Xie (6 shared papers)Lei Han (4 shared papers)Hongzhou Lu (1 shared paper)Min Zhang (1 shared paper)Jiangtao Lin (2 shared papers)Kaisheng Yin (2 shared papers)Hui Faye Xiao (2 shared papers)Xue Tian (3 shared papers)
- Journals
- Experimental Lung Research (2 papers)Allergy (1 paper)Toxicology and Applied Pharmacology (1 paper)Annals of Translational Medicine (1 paper)BMC Medicine (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Fengming Ding
17 papers receiving 523 citations
Peers
Comparison fields: 5 of 76
- Infectious Diseases 148
- Physiology 125
- Molecular Biology 119
- Pulmonary and Respiratory Medicine 57
- Immunology 24
Countries citing papers authored by Fengming Ding
This map shows the geographic impact of Fengming Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengming Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengming Ding more than expected).
Fields of papers citing papers by Fengming Ding
This network shows the impact of papers produced by Fengming Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengming Ding. The network helps show where Fengming Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengming Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 150 | |
| 2 | 2018 | 63 | |
| 3 | 2019 | 59 | |
| 4 | 2008 | 55 | |
| 5 | 2021 | 53 | |
| 6 | 2007 | 41 | |
| 7 | 2022 | 19 | |
| 8 | 2021 | 17 | |
| 9 | 2014 | 16 | |
| 10 | 2018 | 16 | |
| 11 | 2012 | 11 | |
| 12 | 2017 | 11 | |
| 13 | 2022 | 11 | |
| 14 | 2021 | 9 | |
| 15 | 2018 | 2 | |
| 16 | 2022 | 2 | |
| 17 | 2022 | 2 |
About Fengming Ding
Fengming Ding is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Infectious Diseases, Immunology and Oncology, having authored 17 papers that have together received 537 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (4 papers), COVID-19 Clinical Research Studies (3 papers), Bacterial biofilms and quorum sensing (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Cystic Fibrosis Research Advances (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), T-cell and B-cell Immunology (2 papers) and Protease and Inhibitor Mechanisms (1 paper). The work is most often cited by research in Infectious Diseases (148 citations), Physiology (125 citations), Molecular Biology (119 citations), Pulmonary and Respiratory Medicine (57 citations) and Immunology (24 citations). Fengming Ding has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Guogang Xie, Lei Han, Hongzhou Lu, Min Zhang, Jiangtao Lin, Kaisheng Yin, Hui Faye Xiao, Xue Tian, Xin Zhou and Wuping Bao. Their work appears in journals such as Experimental Lung Research, Allergy, Toxicology and Applied Pharmacology, Annals of Translational Medicine and BMC Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.